<SEC-DOCUMENT>0001437749-25-008832.txt : 20250324
<SEC-HEADER>0001437749-25-008832.hdr.sgml : 20250324
<ACCEPTANCE-DATETIME>20250324070551
ACCESSION NUMBER:		0001437749-25-008832
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20250324
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250324
DATE AS OF CHANGE:		20250324

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Moleculin Biotech, Inc.
		CENTRAL INDEX KEY:			0001659617
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				474671997
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37758
		FILM NUMBER:		25762201

	BUSINESS ADDRESS:	
		STREET 1:		5300 MEMORIAL DRIVE
		STREET 2:		SUITE 950
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77007
		BUSINESS PHONE:		713-300-5160

	MAIL ADDRESS:	
		STREET 1:		5300 MEMORIAL DRIVE
		STREET 2:		SUITE 950
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77007
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>mbrx20250321_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:rr="http://xbrl.sec.gov/rr/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:mbrx="http://www.mbrx.com/20250324"><head>
	<title>mbrx20250321_8k.htm</title>

	<!-- Generated by ThunderDome Portal - 3/21/2025 7:33:04 PM -->
<meta http-equiv="Content-Type" content="text/html"/></head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;"><div style="display: none">
<ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="d20258K" name="dei:AmendmentFlag" id="ixv-212">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d20258K" name="dei:EntityCentralIndexKey" id="ixv-213">0001659617</ix:nonNumeric>

</ix:hidden>
<ix:references>
<link:schemaRef xlink:href="mbrx-20250324.xsd" xlink:type="simple"/>
</ix:references>
<ix:resources>
<xbrli:context id="d20258K">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001659617</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-03-24</xbrli:startDate>
<xbrli:endDate>2025-03-24</xbrli:endDate>
</xbrli:period>
</xbrli:context>



</ix:resources>
</ix:header>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>UNITED STATES</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SECURITIES AND EXCHANGE COMMISSION</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>WASHINGTON, D.C. 20549</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>FORM <ix:nonNumeric contextRef="d20258K" name="dei:DocumentType" id="ixv-223">8-K</ix:nonNumeric></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CURRENT REPORT</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): <ix:nonNumeric contextRef="d20258K" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="ixv-224">March 24, 2025</ix:nonNumeric></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="text-align:center;font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><img alt="a01.jpg" src="a01.jpg"/></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d20258K" name="dei:EntityRegistrantName" id="ixv-225">MOLECULIN BIOTECH, INC.</ix:nonNumeric></b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Exact Name of Registrant as Specified in its Charter)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:15.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20258K" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="ixv-39">D<span style="text-transform:uppercase;">elaware</span></ix:nonNumeric></div>
			</td>
			<td style="vertical-align:middle;width:15.7%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d20258K" name="dei:EntityFileNumber" id="ixv-226">001-37758</ix:nonNumeric></b></div>
			</td>
			<td style="vertical-align:middle;width:15.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d20258K" name="dei:EntityTaxIdentificationNumber" id="ixv-227">47-4671997</ix:nonNumeric></b></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:15.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(State or Other Jurisdiction of Incorporation</div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">or Organization)</div>
			</td>
			<td style="vertical-align:top;width:15.7%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Commission File No.)</div>
			</td>
			<td style="vertical-align:top;width:15.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(I.R.S. Employer Identification No.)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d20258K" name="dei:EntityAddressAddressLine1" id="ixv-228">5300 Memorial Drive, Suite 950</ix:nonNumeric>, <ix:nonNumeric contextRef="d20258K" name="dei:EntityAddressCityOrTown" id="ixv-229">Houston</ix:nonNumeric>, <ix:nonNumeric contextRef="d20258K" name="dei:EntityAddressStateOrProvince" id="ixv-230">TX</ix:nonNumeric> <ix:nonNumeric contextRef="d20258K" name="dei:EntityAddressPostalZipCode" id="ixv-231">77007</ix:nonNumeric></b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Address of principal executive offices and zip code)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(<ix:nonNumeric contextRef="d20258K" name="dei:CityAreaCode" id="ixv-232">713</ix:nonNumeric>) <ix:nonNumeric contextRef="d20258K" name="dei:LocalPhoneNumber" id="ixv-233">300-5160</ix:nonNumeric></b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Registrant&#8217;s telephone number, including area code)</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Former name or former address, if changed from last report)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 24pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<i>see </i>General Instruction A.2. below):</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20258K" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="ixv-234">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:3.3%;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20258K" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="ixv-235">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:3.3%;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20258K" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="ixv-236">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:3.3%;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20258K" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="ixv-237">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-14(c))</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).&#160; Emerging growth company&#160;&#9744;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;<ix:nonNumeric contextRef="d20258K" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="ixv-238">&#9744;</ix:nonNumeric></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-width: 1px; border-style: solid; border-color: black black rgb(0, 0, 0); vertical-align: bottom; width: 0.8%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Title of each class</b></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-top: 1px solid black; border-right: 1px solid black;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Trading Symbol (s)</b></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.8%; border-top: 1px solid black; border-right: 1px solid black;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Name of each exchange on which registered</b></div>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.8%; border-left: 1px solid black; border-right: 1px solid black;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20258K" name="dei:Security12bTitle" id="ixv-239">Common Stock</ix:nonNumeric>, par value $.001 per share</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20258K" name="dei:TradingSymbol" id="ixv-240">MBRX</ix:nonNumeric></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.8%; border-right: 1px solid black;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">The <ix:nonNumeric contextRef="d20258K" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-241">NASDAQ</ix:nonNumeric> Stock Market LLC</div>
			</td>
		</tr>

</tbody></table>

<div style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Item 2.02</b>&#160;&#160;&#160;&#160;&#160;<b>Results of Operations and Financial Condition.</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On March 24, 2025, Moleculin Biotech, Inc. (the &#8220;Company&#8221;) issued a press release announcing its financial results for the year ended December 31, 2024 and recent operational highlights. A copy of the press release is attached to this report as Exhibit 99.1 and is incorporated by reference herein.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Item 9.01 </b>&#160;&#160;&#160;&#160;&#160;<b>Financial Statements and Exhibits.</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(d)&#160;&#160;&#160;&#160;&#160;Exhibits.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:10%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Exhibit</b></div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>No.</b></div>
			</td>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Description</b></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:10%;">&#160;</td>
			<td style="vertical-align:top;width:auto;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:10%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">99.1</div>
			</td>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="ex_793112.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline;">Press Release dated March 24, 2025</span></a></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:10%;">&#160;</td>
			<td style="vertical-align:top;width:auto;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:10%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">104</div>
			</td>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cover page Interactive Data File (embedded within the Inline XBRL document)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="text-decoration: underline;">SIGNATURE</span></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 16pt;text-indent:36pt;">Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:23.1%;">&#160;</td>
			<td style="vertical-align:middle;width:23.1%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>MOLECULIN BIOTECH, INC.</b></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:23.1%;">&#160;</td>
			<td style="vertical-align:middle;width:23.1%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:23.1%;">&#160;</td>
			<td style="vertical-align:middle;width:23.1%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:23.1%;">&#160;</td>
			<td style="vertical-align:middle;width:23.1%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Date:&#160;&#160;March 24, 2025</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:23.1%;">&#160;</td>
			<td style="vertical-align:middle;width:23.1%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:23.1%;">&#160;</td>
			<td style="vertical-align:middle;width:23.1%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By: &#160;<span style="text-decoration: underline;">/s/ Jonathan P. Foster</span>&#160;</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:23.1%;">&#160;</td>
			<td style="vertical-align:middle;width:23.1%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Jonathan P. Foster</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:23.1%;">&#160;</td>
			<td style="vertical-align:middle;width:23.1%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chief Financial Officer</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>
</div>


</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex_793112.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html><head>
	<title>ex_793112.htm</title>
	<!-- Generated by ThunderDome Portal - 3/21/2025 8:32:34 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 99.1</b></font></p>

<p style="margin: 0px 0pt; text-align: left; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font><img alt="a01.jpg" src="a01.jpg"></p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt;"><b>Moleculin Reports Full Year 2024 Financial Results and Provides Corporate Update</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt;"><i>&#8211;Continued progress in pivotal, adaptive Phase 3 clinical trial (the </i>&#8220;<i>MIRACLE</i>&#8221;<i> trial) toward first subject treated, on track to take place in the first quarter of 2025</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt;"><i>&#8211;Multiple subjects currently being screened in first MIRACLE site activated</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt;"><i>&#8211; Initial data readout of the Phase 3 MIRACLE trial expected in the second half of 2025</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt;"><i>&#8211; Company to host conference call and webcast today, Monday, March 24</i><i><sup style="vertical-align:top;line-height:120%;">th</sup></i><i> at 8:30 AM ET</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>HOUSTON,</b>&nbsp;<b>March 24, 2025</b>&nbsp;&#8212;&nbsp;<b>Moleculin Biotech, Inc.</b>, (Nasdaq: MBRX) (&#8220;Moleculin&#8221; or the &#8220;Company&#8221;), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat cancers and viruses, today reported its financial results for the fiscal year ended&nbsp;December 31, 2024. As previously announced, the Company will host a conference call and live audio webcast to discuss the operational and financial results at 8:30 AM ET on Monday, March 24, 2025 (details below).</p>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#8220;This last year proved to be a very productive and substantial year for Moleculin. We believe that we continue to successfully execute on activities for our MIRACLE trial, supported by a growing body of positive preliminary data and encouraging interactions with FDA and clinical sites,&#8221; commented Walter Klemp, Chairman and Chief Executive Officer of Moleculin. &#8220;Looking ahead, we look forward to an exciting year with a number of potential value-driving milestones expected in the coming months. Importantly, with the clinical and regulatory progress made to date, we still expect to unblind preliminary data from the first 45 subjects in the second half of this year. Our team is dedicated to advancing the development of Annamycin and we look forward to providing additional updates.&#8221;</p>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Recent Highlights</b></p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Expanded global exclusivity for Annamycin with Notice of Intent to Grant for the European patent application titled, &#8220;<i>Method of Reconstituting Liposomal Annamycin</i>&#8220;;</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width: 18pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Received positive FDA guidance for acceleration of its registration-enabling MIRACLE trial for R/R Acute Myeloid Leukemia (AML) resulting in a smaller number of subjects in MIRACLE;</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width: 18pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Received first country regulatory approval in Europe to begin enrolling for the MIRACLE trial;</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width: 18pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Received US Institutional Review Board (IRB) approval for pivotal, adaptive Phase 3 clinical trial (the &#8220;MIRACLE&#8221;&nbsp;trial) and engaged a leading contract research organization (CRO); and,</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width: 18pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Announced new preclinical findings demonstrating significant activity of Annamycin in Venetoclax resistant AML model.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Clinical Development Update</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><u>Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company is currently evaluating Annamycin in combination with Cytarabine (also known as &#8220;Ara-C&#8221; and for which the combination of Annamycin and Ara-C is referred to as &#8220;AnnAraC&#8221;) in a Phase 3 pivotal trial for the treatment of AML patients who are refractory to or relapsed after induction therapy (R/R AML). This Phase 3 &#8220;MIRACLE&#8221; trial (derived from <b>M</b>olecul<b>i</b>n <b>R</b>/R AML <b>A</b>nnAraC <b>Cl</b>inical <b>E</b>valuation) will be global, including sites in the US, Europe and the Middle East.</p>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The MIRACLE study is a Phase 2B/3 clinical trial whereby data from the 2B portion will be combined with the Phase 3 portion. MIRACLE is subject to appropriate future filings with and potential additional feedback from the FDA and their foreign equivalents, utilizes an adaptive design whereby the first 75 to 90 subjects will be randomized (1:1:1) in Part A of the trial to receive high dose cytarabine (HiDAC) combined with either placebo, 190 mg/m2 of Annamycin, or 230 mg/m2 of Annamycin, which Annamycin doses were specifically recommended by the FDA in the Company&#8217;s end of Phase 1B/2 meeting. The amended protocol allows for the unblinding of preliminary primary efficacy data (Complete Remission or CR) and safety/tolerability of the three arms at 45 subjects, in addition to the conclusion of Part A (at 75 to 90 subjects). The first early unblinding will yield 30 subjects with Annamycin (190mg/m2 and 230/m2) and HiDAC and 15 subjects with just HiDAC. The Company expects to reach the first unblinding (45 subjects) in the second half of 2025, in addition to the second unblinding, which is expected in the first half of 2026. This accelerated estimated timeline is due to the positive response the Company received in meetings during December with potential investigators regarding recruitment for the trial.</p>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Early activities include: Multiple first subjects in Ukraine are being screened and we expect to begin treatment by the end of March; Corresponding ethic committee approvals were received recently in Georgia and Egypt with the appropriate regulatory approvals remaining; and, multiple site evaluation and initiation visits are occurring and/or being scheduled.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">For Part B of the trial, approximately 220 additional subjects will be randomized to receive either HiDAC plus placebo or HiDAC plus the optimum dose of Annamycin (randomized 1:1). The selection of the optimum dose will be based on the overall balance of safety, pharmacokinetics and efficacy, consistent with the FDA&#8217;s new Project Optimus initiative. For more information about the MIRACLE trial, visit clinicaltrials.gov and reference identifier NCT06788756.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Expected Milestones for Annamycin AML Development Program</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">1Q &#8211;&nbsp;3Q 2025 &#8211;&nbsp;Update on MIRACLE trial site selection/approvals by countries</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width: 18pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">1Q 2025 &#8211;&nbsp;First subject enrolled and treated in MIRACLE trial</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width: 18pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">2025 &#8211;&nbsp;Recruitment update for MIRACLE trial</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width: 18pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">2H 2025 &#8211;&nbsp;Data readout (n=45) unblinded efficacy/safety review</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width: 18pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">2H 2025 &#8211;&nbsp;2026 &#8211;&nbsp;Impact of data readout (n=45) on regulatory pathway; Recruitment update</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width: 18pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">1H 2026 &#8211;&nbsp;Interim efficacy and safety data (n=~75-90) unblinded and Optimum Dose set for MIRACLE trial</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width: 18pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">2027 &#8211;&nbsp;Begin enrollment of 3<sup style="vertical-align:top;line-height:120%;">rd</sup>&nbsp;line subjects in MIRACLE2</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width: 18pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">2027 &#8211;&nbsp;Enrollment ends in 2<sup style="vertical-align:top;line-height:120%;">nd</sup>&nbsp;line subjects</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width: 18pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">2028 &#8211;&nbsp;Primary efficacy data for 2<sup style="vertical-align:top;line-height:120%;">nd</sup>&nbsp;line subjects in MIRACLE</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width: 18pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">2028 &#8211;&nbsp;Begin submission of a Rolling New Drug Application (NDA) for the treatment of R/R AML for accelerated approval on primary endpoint of CR from MIRACLE</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width: 18pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">2028 &#8211;&nbsp;Primary efficacy data for 2<sup style="vertical-align:top;line-height:120%;">nd</sup>&nbsp;line subjects</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width: 18pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">2028 &#8211;&nbsp;Rolling NDA submission begins</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><u>Soft Tissue Sarcoma (STS) Lung Metastases</u></b></p>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">As previously announced, the Company completed enrollment in the Phase 2 portion of its U.S. Phase 1B/2 clinical trial evaluating Annamycin as monotherapy for the treatment of soft tissue sarcoma lung metastases. Subjects who had stable disease at the time of study discontinuation were followed for progression free response and overall survival. The clinical study report is finalized but not yet filed and is expected to be released by the end of April 2025.</p>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Expected Milestones for Annamycin STS Lung Mets Development Program</b></p>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">1H 2025 &#8211;&nbsp;Final MB-107 data readout</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width: 18pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">2025 &#8211;&nbsp;Identify next phase of development / pivotal IIT (investigator-initiated-trial) program</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Annamycin currently has Fast Track Status and Orphan Drug Designation from the FDA for the treatment of relapsed or refractory acute myeloid leukemia, in addition to Orphan Drug Designation for the treatment of soft tissue sarcoma. Furthermore, Annamycin has Orphan Drug Designation for the treatment of relapsed or refractory acute myeloid leukemia from the European Medicines Agency (EMA).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Summary of Financial Results for the Full Year 2024</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Research and development (R&amp;D) expense was $17.7 million and $19.5 million for the years ended December 31, 2024 and 2023, respectively. The decrease in R&amp;D of $1.8 million is mainly related to the $1.5 million WPD sublicense termination in 2023, which enabled the reacquisition of our intellectual property rights in certain territories, including parts of the European Union.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">General and administrative (G&amp;A) expenses were $8.8&nbsp;million and $10.0&nbsp;million for the years ended December 31, 2024 and 2023, respectively. The decrease&nbsp;in G&amp;A of $1.2&nbsp;million was mainly attributable to a decrease in regulatory and legal services, and consulting &amp; advisory fees.&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">As of December 31, 2024, the Company had cash and cash equivalents of $4.3 million. The Company believes that the existing cash and cash equivalents as of December 31, 2024, along with $9.3 million in gross proceeds received as part of the February 2025 financing activities will be sufficient to fund our planned operations into the third quarter of 2025.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Conference Call and Webcast </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Moleculin management will host its quarterly conference call and webcast for investors, analysts, and other interested parties on Monday, March 24, 2024 at 8:30 AM ET.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Interested participants and investors may access the conference call by dialing (877) 407-0832 (domestic) or (201) 689-8433 (international) and referencing the Moleculin Biotech Conference Call. The live audio webcast will be accessible on the Events page of the Investors section of the Moleculin website, moleculin.com, and will be archived for 90 days.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>About Moleculin Biotech, Inc.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Moleculin Biotech, Inc. is a Phase 3 clinical stage pharmaceutical company advancing a pipeline of therapeutic candidates addressing hard-to-treat tumors and viruses. The Company&#8217;s lead program, Annamycin, is a next-generation anthracycline designed to avoid multidrug resistance mechanisms and to eliminate the cardiotoxicity common with currently prescribed anthracyclines. Annamycin is currently in development for the treatment of relapsed or refractory acute myeloid leukemia (AML) and soft tissue sarcoma (STS) lung metastases.</p>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company is initiating the MIRACLE (<b>M</b>olecul<b>i</b>n <b>R</b>/R AML <b>A</b>nnAraC <b>Cl</b>inical <b>E</b>valuation) Trial (MB-108), a pivotal, adaptive design Phase 3 trial evaluating Annamycin in combination with cytarabine, together referred to as AnnAraC, for the treatment of relapsed or refractory acute myeloid leukemia. Following a successful Phase 1B/2 study (MB-106), with input from the FDA, the Company believes it has substantially de-risked the development pathway towards a potential approval for Annamycin for the treatment of AML. This study is subject to appropriate future filings with potential additional feedback from the FDA and their foreign equivalents.</p>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Additionally, the Company is developing WP1066, an Immune/Transcription Modulator capable of inhibiting p-STAT3 and other oncogenic transcription factors while also stimulating a natural immune response, targeting brain tumors, pancreatic and other cancers. Moleculin is also engaged in the development of a portfolio of antimetabolites, including WP1122 for the potential treatment of pathogenic viruses, as well as certain cancer indications.</p>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">For more information about the Company, please visit www.moleculin.com and connect on X, LinkedIn and Facebook.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Forward-Looking Statements</b></p>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Some of the statements in this release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation, the timing of the achievements of each of the milestones in this press release. Moleculin will require significant additional financing, for which the Company has no commitments, in order to conduct its clinical trials as described in this press release, and the milestones described in this press release assume the Company&#8217;s ability to secure such financing on a timely basis. Although Moleculin believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. Moleculin has attempted to identify forward-looking statements by terminology including &#8216;believes,&#8217; &#8216;estimates,&#8217; &#8216;anticipates,&#8217; &#8216;expects,&#8217; &#8216;plans,&#8217; &#8216;projects,&#8217; &#8216;intends,&#8217; &#8216;potential,&#8217; &#8216;may,&#8217; &#8216;could,&#8217; &#8216;might,&#8217; &#8216;will,&#8217; &#8216;should,&#8217; &#8216;approximately&#8217; or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, including those discussed under Item 1A. &#8220;Risk Factors&#8221; in our most recently filed Form 10-K filed with the Securities and Exchange Commission (SEC) and updated from time to time in our Form 10-Q filings and in our other public filings with the SEC. Any forward-looking statements contained in this release speak only as of its date. We undertake no obligation to update any forward-looking statements contained in this release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events.</p>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Investor Contact:</b><br>
JTC Team, LLC</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Jenene Thomas</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(908) 824-0775</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">MBRX@jtcir.com</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;">

		<tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%; border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Moleculin Biotech, Inc.</b></p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);"><b>&nbsp;</b></td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);"><b>&nbsp;</b></td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);"><b>&nbsp;</b></td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);"><b>&nbsp;</b></td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);"><b>&nbsp;</b></td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"><b>&nbsp;</b></td>
		</tr>
		<tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Unaudited Condensed Consolidated Balance Sheets</b></p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&nbsp;</b></td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&nbsp;</b></td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&nbsp;</b></td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&nbsp;</b></td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"><b>&nbsp;</b></td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"><b>&nbsp;</b></td>
		</tr>
		<tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>(in thousands)</b></p>
			</td>
			<td id=".lead.D2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td colspan="2" id=".amt.D2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>December 31, 2024</b></p>
			</td>
			<td id=".trail.D2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".lead.D3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td colspan="2" id=".amt.D3" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>December 31, 2023</b></p>
			</td>
			<td id=".trail.D3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Current assets:</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Cash and cash equivalents</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.2" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">4,278</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.3" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">23,550</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Prepaid expenses and other current assets</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">916</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">2,723</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Total current assets</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">5,194</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">26,273</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Furniture and equipment, net</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">159</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">272</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Intangible assets</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">11,148</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">11,148</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Operating lease right-of-use asset</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">424</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">524</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Total assets</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.2" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;">16,925</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.3" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;">38,217</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Current liabilities:</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Accounts payable and accrued expenses and other current liabilities</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td>
			<td id=".amt.2" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">5,359</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td>
			<td id=".amt.3" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">6,815</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Total current liabilities</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">5,359</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">6,815</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Operating lease liability - long-term, net of current portion</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">358</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">474</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Warrant liability - long term</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">5,229</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">4,855</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Total liabilities</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">10,946</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">12,144</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Total stockholders' equity</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">5,979</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">26,073</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Total liabilities and stockholders' equity</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.2" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;">16,925</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.3" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;">38,217</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;">

		<tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Unaudited Condensed Consolidated Statements of Operations</b></p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);"><b>&nbsp;</b></td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);"><b>&nbsp;</b></td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);"><b>&nbsp;</b></td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);"><b>&nbsp;</b></td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);"><b>&nbsp;</b></td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;"><b>&nbsp;</b></td>
		</tr>
		<tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.D3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td colspan="6" id=".amt.D3" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Year Ended December 31,</b></p>
			</td>
			<td id=".trail.D3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>(in thousands, except share and per share amounts)</b></p>
			</td>
			<td id=".lead.D2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" id=".amt.D2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>2024</b></p>
			</td>
			<td id=".trail.D2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".lead.D3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" id=".amt.D3" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>2023</b></p>
			</td>
			<td id=".trail.D3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Revenues</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Operating expenses:</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Research and development</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">17,729</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">19,487</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">General and administrative and depreciation and amortization</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">8,912</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">10,144</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Total operating expenses</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">26,641</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">29,631</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Loss from operations</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(26,641</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(29,631</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Other income:</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Gain (loss) from change in fair value of warrant liability</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">6,125</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(1,044</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Transaction costs allocated to warrant liabilities</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(993</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(510</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Loss on issuance of warrant liabilities</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(847</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Other income, net</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">43</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">48</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Interest income, net</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">550</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">1,368</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Net loss</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;">(21,763</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;">(29,769</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Net loss per common share - basic and diluted</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.2" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;">(6.32</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.3" style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;">(15.07</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Weighted average common shares outstanding - basic and diluted</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">3,442,997</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,975,610</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>mbrx-20250324.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 3/23/2025 3:33:31 PM-->
<xsd:schema xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:mbrx="http://www.mbrx.com/20250324" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.mbrx.com/20250324">
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/stpr/2024" schemaLocation="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/sic/2024" schemaLocation="https://xbrl.sec.gov/sic/2024/sic-2024.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/currency/2024" schemaLocation="https://xbrl.sec.gov/currency/2024/currency-2024.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/exch/2024" schemaLocation="https://xbrl.sec.gov/exch/2024/exch-2024.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/cyd-8k-sub/2024" schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-8k-sub-2024.xsd"/>

<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mbrx-20250324_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mbrx-20250324_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mbrx-20250324_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="statement-document-and-entity-information" roleURI="http://www.mbrx.com/20250324/role/statement-document-and-entity-information">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:presentationLink</link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element abstract="true" id="mbrx_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>mbrx-20250324_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 3/23/2025 3:33:31 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
<link:roleRef roleURI="http://www.mbrx.com/20250324/role/statement-document-and-entity-information" xlink:href="mbrx-20250324.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:definitionLink xlink:role="http://www.mbrx.com/20250324/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>


<link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>mbrx-20250324_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 3/23/2025 3:33:31 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
<link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:label xlink:label="dei_EntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:label xlink:label="dei_LegalEntityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentType-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Type</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentPeriodEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Period End Date</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:label xlink:label="dei_EntityRegistrantName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Registrant Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityIncorporationStateCountryCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Incorporation, State or Country Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityFileNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, File Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityTaxIdentificationNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Tax Identification Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressAddressLine1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Address Line One</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressCityOrTown-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, City or Town</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressStateOrProvince-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, State or Province</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressPostalZipCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Postal Zip Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:label xlink:label="dei_CityAreaCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:label xlink:label="dei_LocalPhoneNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:label xlink:label="dei_WrittenCommunications-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:label xlink:label="dei_SolicitingMaterial-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementIssuerTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:label xlink:label="dei_EntityEmergingGrowthCompany-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Emerging Growth Company</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:label xlink:label="dei_Security12bTitle-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:label xlink:label="dei_TradingSymbol-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:label xlink:label="dei_SecurityExchangeName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:label xlink:label="dei_AmendmentFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:label xlink:label="dei_EntityCentralIndexKey-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Central Index Key</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey-label" xlink:type="arc"/>

</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>mbrx-20250324_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 3/23/2025 3:33:31 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.mbrx.com/20250324/role/statement-document-and-entity-information" xlink:href="mbrx-20250324.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:presentationLink xlink:role="http://www.mbrx.com/20250324/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>

<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>

<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" xlink:type="arc"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>a01.jpg
<TEXT>
begin 644 a01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!P17AI9@  34T *@    @ !@$Q  (
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M5"6BGROE>MM)6MNFO4[2BO Q_P %+_A&NM?89-<O89O.\AFDT^58T;.W);&
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M]MRQ\<>-?"K7OA7Q%I>N>$7N?^$NM6M69?#WF)Y"AFQ\ZO,8V4K_  #-6O\
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M6%O[P&]#_P"/*:^MO^"=GQ-T'5?V2O#EK'JMBEUH<<T%]#),J/;-YTC L">
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MXWQUZ/\ \$A?^3:M>_[&";_TFMZ^9RG_ ).OB?\ "_\ TW ^HS;_ )-+A?\
M$O\ T[,_/+Q=_P C7J7_ %]2?^A&ONW_ ()R_M9_\)W\+=2^'FNW!;6-%T^9
MM*ED/S7=L$.8O=H^WJG^Z:^0_A1I]OJ_[4&AVMU#'<6MUXABBFBD7<DB-. R
MD>A!(KM/VM_@'JW[&7QZCNM#FN;;2KJ1KW1+Q3S&O\4)/=DSM(/52">I%?D7
M!N89ED<Y\185<U",_9U8K^66J;^>SZ223T9^P<:9?EF>PI\-XI\M>4/:TI/^
M:.C2^6ZZQ;:U1S_[%G_)W'@7_L+Q?S-?KU7Y!_L3OO\ VL_ C'OJ\1_G7Z^5
M^V_1Y_Y$^*_Z^_\ MD3\-^D9_P CG"_]>O\ VZ1!J>F6VM:=/9WEO!=VETAB
MFAFC$D<J$8*LIX((X(/!K \)_!3P;X!U;[?H7A'PSHM]L,7VBPTN"VFV'&5W
M(H.#@<9[5TU%?T-3Q-:$'3A)J+W2;L_5=3^=W%-W:,#XI?"[P_\ &OX>ZMX5
M\5:7;ZUX?UR VU[93@[)T)!QP0000""""" 0017SEJO_  3-_9__ &7/#NJ?
M$3PM\+]!M?$7@>PN=;TV::>YF6*XMX7D1BK2$'#*#[=1R :\S_:+_P""KGQ)
M\7?';Q-\+?V;OA/>>//$W@6Y,?B+5-57R]/M"C'=$@$B99]K*K.ZDD':K8S7
MH/[)/[:\/_!3_P"!WQ0\$7WAG7/AOXXT6QG\.>(;*]C\Y=.N+F&:'?&3M9MK
M*^4<*P*XYZU^H8?ASBS),L^MSJRI863A*K"%:S4*EE&56E&7,HS3LG*.JT>Z
MOQT<7A*F)2^TM$[=MTG;IUL?.G[&G[$>J?\ !6CX<VGQJ_: \=:WXAM=<^U0
M:'X<TMS8V6CJDKPF10,@,&0D #G +L_(IWPY_8Z\8>(_VL-9_9EUSXP^+M6^
M$O@_2HO$9M!B.YNX)'B5+)Y,DA!OSC)3 RJ*3Q?^!=]^U1_P2X\)V?PGA^&&
MF?&#PIYDT/A;6-%9XOLLTLCRXNL#*Q[G9CY@7'($I&,?3'[#_P"R/XX^'7Q*
M\4?%CXK^(K+6/B3XZM(;2[L]-A$=AI%O'M*0(>KD;5&>GR]6/S&N/L95EB:T
MHUJ<L))OZO&FXM*%_=M&*3@U'27,DW+>[U/Z0RGBK&Y-E^+Q53%4O9.G;"P7
M).4:G-&TX1Y6Z4H0Y^:;Y7S-6<G:WG7[3O[%6D_LN3^'_%7P<UK5/ASJFN:G
M8>%+JTL7,MM>I=2"$2%7)Q(N=V><D9X;YJ]#U;]D#X;_  M\;?##28[&-KQY
MKQ)KFZFS<:XPA,A\_P#Y[-YQ20 ]-O&!Q7$?$_7/'G[>&E:MXB\-:EI_@+P!
M\-=5FOM'OKV(7%QKFHV#,#.P!(BMT(?'4D\D'&![A\!O'FH?'&W\+7WB#PY8
MO?:+I%OJ%SJ@&U;;4YX!O@A0Y9=L4AWDG&6VC[I(_F_&8'"XC&2ISI?$X./,
MKQTDG.RUM=+5V2=EJT<^<9IGN&RRC+'8MSJTE4C62G^]BY0M2C4G9<[AS/3G
MG*#DXV3T7,_MB?LH>*/VA?BIX%U;2;[1[;3/"LGFS1W<LBR.QF1VVA48?=C'
M4CG\ZP?V]/V$-:_:@\<Z+KGAZ]T>QN+2R-G=_;7D0R .60KM1NFY^N.U?4U%
M:YIP%E.81Q4<5&3^LRA*?O/>"M&W;33S/SO*_$#-\NEA9X645]6C.,/=6TW>
M7-WN]?(^;)_V*M6M?V#_ /A5]E>:6NO3NL\]R[O]F:3[2)6P=N[&T!1\O;M5
MG_@G_P#LC>(?V4[+Q3'KU]I-XVN/;-!]AD=]GE"7=NW(O7S!C&>AKZ*HJ\/P
M+E-#'X;,J46JF'IJG#5V44I+5=7:3U,\3QYF]?+\3EM62=/$5'5GIJY-QEH^
MBO%:'RW^V!_P37T_X^^)I_$WAO4+?0?$%US=Q31DVMZV,;SMY1SW(!!ZXSDG
MYU3_ (),_%-[WR&N?#2V^?\ 6F_?:/?'EY_2OTNHKP,\\(.&\TQ<L;5IRA.3
MO+DE9-]6UJKOK:U]]SZ#(O&/B;*L)'!4:D9PBK1YX\SBNB3T=ETO>VVQ\W_L
M<?\ !/+2OV:M5'B#5KZ/7O%'EE(9$C*6]B&&&\L'EF(XWG'!( &3FI^WY^Q=
MXE_:J\0>'+K0;_1K./1[>:&47LDB%B[*1MVHW]WOBOINBO=J< Y*\F>0PI<M
M!M-I-IMIIW<M6W=*[?338\*GX@YVLZ7$$ZO-B$FDY)-)--64=$E9O1===S\X
M1_P1_P#B(/\ F.^$?_ B?_XU7H'[+G_!-7QM\$OCOX?\4:IJWARXL=)E>26.
MWFF:5@8V48#1@=6'4U]O45\W@/!GAK!XFGBZ,)\].2DKS;UBTU^*/I<P\:N)
M\9A:F$KSAR5(N+M!)VDK/7T9\*?M#_\ !,+QQ\7/C=XF\2Z?J_AF"RUF^>YA
MCGFF615..& C(S]":XW_ (<__$3_ *#GA'_P(G_^-5^CM%3C/!?AG$XB>)JP
MGS3DY/WWNW=_B5@_&[BC"X>&&I3ARPBHKW%LDDOP1\C?L.?L#>+/V9OC)/XB
MUO4]!O+.339;,1V<LK2;W>-@<-&HQ\A[UU/[9?\ P3VTW]IC5%\0:1?1:%XH
M6,1S221EK>^5>%\P#E6 XWC/  (.!CZ0HKZ##^'>1T\G>1NDY4')RM)MM2?5
M2T:?IYK9L^=Q'B1GM7.5GRJJ-=14;Q22<5T<=4UZ^3W2/S1D_P""3/Q46\\E
M;CPTUOG'F_;WV_7'EY_2OI_]BW_@GY8?LR:B^OZO?0ZUXHDB,,<D2%;>Q1OO
M"/=RS'IN(''  R<_1]%>7P_X2\.Y1C(X[#TY2J1UCSRNHONEHKKHW>VZU/4X
MA\7N(\XP<L!B*D8TY:24(\KDNS=V[/JE:^ST/'?VOOV/='_:O\*V\-Q<'2]<
MTS<;#4%CW[ WWHW7(W(< ]001D=P?C?5O^"2GQ0TZZ:.SO/#-[#G D6]>/(^
MC1@U^E5%=/$WA?D&>XGZ[C*;C4=DY0ERMVVNM4W;2]KVTOHCGX7\5.(,APOU
M+!U%*DFVHSCS)7U=GHTF];7M?6VK/B/]FC_@D_-X5\86>M^/M2T^^AL)!-%I
M=D6=)G!R/-=@OR@C[H!SW.,@_1/[8_P/U/\ :%^ ^H>%M'GL;6^NIX)$>Z9E
MB 20,<E58]!QQ7J=%=^5\ 9+E^5ULIPM-JG634W=N4KJVLO1Z6T71:L\_-?$
M+.\QS2CF^+J*52BTX*R48V=](^;6M]7U>B/SA'_!'[XB#_F.>$?_  (G_P#C
M5.'_  2 ^(H/_(>\)?\ @1/_ /&J_1RBODO^(%\*_P D_P#P-GU__$>.*_YX
M?^ (^7_VZ/V)_$W[3L_A-M#U#1;,:#9R6\_VR21=[,4P5VHW'RGKBNR_86_9
MKUK]F+X1ZGH&N7>FWEU>:I)>H]D[M&$:*) "653G*'MW%>W45]GA^"<KH9U+
M/Z:?MY*S?,[6Y5';T2/BL1QSFM?)(\/U)1]A%W2Y5>_,Y;^K9\&_#_\ X)<^
M.O"GQLTGQ)<:QX8>RL=7COWC2>8R%%E#D &(#=@>N/>OJW]J+]GG3?VE_A-?
M>'KSRX;P?O\ 3KMER;2X .UO7:<E6'<$]\5Z+16.3^'^39;@L1E]"FW3K_&I
M-N^EOE\MGJ;YUXA9UF>-P^88BHE5H? XI*VM_G\]UH?"?[/'_!,+QQ\)/C;X
M9\2:AJWAF:RT>^2YFC@GF:1E'4*#$ 3]2*^[***[.%>#\NX>H3PV6IJ,WS.[
MOK9+\D<7%G&69<18B&)S-IRA'E5E;2[?YL****^H/E3\Z_''[&7[2_[&G[4G
MQ&^(_P  [CP3XXTOXN:A]HU/2-;C^S3Z7*S.8Y V]0Z1M*QR'!(ZQGK7N'_!
M-#]A'Q-^R%#\0/$WCOQ58^*/'WQ5U1-:UQ["V\FSM9@96*1$X+ M,^3M4< !
M1CGZDKSG]I_]JCPC^R+\.%\2^+[JZ6"XNH["QL;& W-_JES(<)!;P@@R2'DX
M'0 DFOT;%<=9WG>%630I0E.JJ<)2A32JU8T[>SC)K=1Y5;E46[+F;L<-#+:<
M*JE"^[LKZ)O>R\SYU_X*+_&37OB;^T;\-OV;?"_B#4/ UQX^)U76_$4,K6LZ
MV$.]OLUI)QNFD,39QTPH.0S"N1_9^^ =W^S/_P %*E\*_#GQGXH\9Z3/X/E?
MQ?)K^H&^?1I69C:.T@55,CNJ$1@!MN\]#7.ZMJ>A_P#!83]NBQ\+^(M \4?#
MWP[\(-).JC3M6MFTKQ+J\UWM7(*DF&W0"-B%;<2R],_+]27WP9TG]@W]FSQ*
MOP9\#W%YKUXRO!;0B74+F^NG*QK-,TC[W6,$N07 PI QNS6?$E.&68+#Y;).
M%7V:<X633E-MJ;G?5N'+:*34=%>]T?OV5YS3RS+(9'2_C8FDX.E*,/9.=67N
MU:E5N_NPY91BERQ:3<M))^=_LQ?LJ_%[PC\.V^$WC&X\+V/P]L+B::?5=&E=
MK[Q%!-(\CVI#?ZI79V\Q\!BIVKG)>OIKX1?#6+X3^"X](CNIKTBXGN7FD&"6
MEE:0@?[*[MHSDX YKC/V9_@/>?#2]U[Q)K6J:[J7B#Q9Y#W0U*]\]H!&F,;%
M/E1LS$DI$-BC:H+!=S>LU^7X?!PC/VS3YM5J[V5]O30^(XVXEKYAC:M/VD)0
ME)3DX0Y(RJ->_.UY-MR;5[I.R:C%62****[CX8**** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KP_]L/]
MA;0OVO\ 5O!.L7.O^(O"7B;P!J)U'1]9T:2-;FW+ ;DVR*\9!*H<E204]"02
MBN_+<TQ67XB.+P<W"<;I-6V:::L[IIIM--6:=F-.SNCH?V=?V4?#_P"SG/K>
MI6M[K7B3Q3XGE676/$6N7(NM3U'8-L<;.%4+&@X6-%"C)XS7I]%%98S&5\55
M=?$2<I/J_)62\DEHDM$M%H:5JU2K/GJ.[\_+1?)+1=D%%%%<ID%%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
&1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Mar. 24, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity, Registrant Name</a></td>
<td class="text">MOLECULIN BIOTECH, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document, Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document, Period End Date</a></td>
<td class="text">Mar. 24,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity, Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity, File Number</a></td>
<td class="text">001-37758<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity, Tax Identification Number</a></td>
<td class="text">47-4671997<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity, Address, Address Line One</a></td>
<td class="text">5300 Memorial Drive, Suite 950<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity, Address, City or Town</a></td>
<td class="text">Houston<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity, Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity, Address, Postal Zip Code</a></td>
<td class="text">77007<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">300-5160<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity, Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MBRX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity, Central Index Key</a></td>
<td class="text">0001659617<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( +DX>%I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( +DX>%K ^N-S[@   "L"   1
M9&]C4')O<',O8V]R92YX;6S-DL%.PS ,AE\%Y=XZ;2F'J,MEB!-(2$P"<8L2
M;XMHFB@Q:O?VM&'KA. !.,;^\_FSY$X'H7W$Y^@#1K*8;B;7#TGHL&%'HB
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MM5II ,,X?<D3$L/<@HL(2W@4R]9<X%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A
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MN!4?\GL(- J<?0QU]T&^L.HLPK4\^#ALMSIMO[+GN4=[3KM_AT]P*"A-$K8
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M"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ N3AX6CJJHN=  0  / (   \
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M 0  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4
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M4')O<',O87!P+GAM;%!+ 0(4 Q0    ( +DX>%K ^N-S[@   "L"   1
M          "  <,   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( +DX
M>%J97)PC$ 8  )PG   3              "  > !  !X;"]T:&5M92]T:&5M
M93$N>&UL4$L! A0#%     @ N3AX6K?DNRA.!   I!   !@
M ("!(0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( +DX
M>%J?H!OPL0(  .(,   -              "  :4,  !X;"]S='EL97,N>&UL
M4$L! A0#%     @ N3AX6I>*NQS     $P(   L              ( !@0\
M %]R96QS+RYR96QS4$L! A0#%     @ N3AX6CJJHN=  0  / (   \
M         ( !:A   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( +DX>%HD
M'INBK0   /@!   :              "  =<1  !X;"]?<F5L<R]W;W)K8F]O
M:RYX;6PN<F5L<U!+ 0(4 Q0    ( +DX>%IED'F2&0$  ,\#   3
M      "  ;P2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(
'  84      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="mbrx20250321_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mbrx.com/20250324/role/statement-document-and-entity-information</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>mbrx-20250324.xsd</File>
    <File>mbrx-20250324_def.xml</File>
    <File>mbrx-20250324_lab.xml</File>
    <File>mbrx-20250324_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="mbrx20250321_8k.htm">mbrx20250321_8k.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>a01.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "mbrx20250321_8k.htm": {
   "nsprefix": "mbrx",
   "nsuri": "http://www.mbrx.com/20250324",
   "dts": {
    "schema": {
     "local": [
      "mbrx-20250324.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/currency/2024/currency-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-8k-sub-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-cr-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/exch/2024/exch-2024.xsd",
      "https://xbrl.sec.gov/sic/2024/sic-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "mbrx-20250324_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "mbrx-20250324_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mbrx-20250324_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "mbrx20250321_8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 36,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 22
   },
   "report": {
    "R1": {
     "role": "http://www.mbrx.com/20250324/role/statement-document-and-entity-information",
     "longName": "000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "d20258K",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mbrx20250321_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d20258K",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mbrx20250321_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.mbrx.com/20250324/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.mbrx.com/20250324/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.mbrx.com/20250324/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.mbrx.com/20250324/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document, Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.mbrx.com/20250324/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document, Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.mbrx.com/20250324/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.mbrx.com/20250324/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.mbrx.com/20250324/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.mbrx.com/20250324/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.mbrx.com/20250324/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.mbrx.com/20250324/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.mbrx.com/20250324/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.mbrx.com/20250324/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.mbrx.com/20250324/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.mbrx.com/20250324/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.mbrx.com/20250324/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.mbrx.com/20250324/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.mbrx.com/20250324/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "cyd_MaterialCybersecurityIncidentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7"
     ]
    },
    "cyd_MaterialCybersecurityIncidentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentAxis",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident [Axis]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7"
     ]
    },
    "cyd_MaterialCybersecurityIncidentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentDomain",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident [Domain]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7"
     ]
    },
    "cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r8"
     ]
    },
    "cyd_MaterialCybersecurityIncidentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentLineItems",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "cyd_MaterialCybersecurityIncidentNatureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentNatureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Nature [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "cyd_MaterialCybersecurityIncidentScopeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentScopeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Scope [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "cyd_MaterialCybersecurityIncidentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentTable",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident [Table]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7"
     ]
    },
    "cyd_MaterialCybersecurityIncidentTimingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentTimingTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Timing [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.mbrx.com/20250324/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.mbrx.com/20250324/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.mbrx.com/20250324/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.mbrx.com/20250324/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.mbrx.com/20250324/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.mbrx.com/20250324/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.mbrx.com/20250324/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 6-K",
   "Section": "General Instruction",
   "Subsection": "B"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Section": "1.05"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Section": "1.05",
   "Subsection": "Instruction",
   "Paragraph": "2"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Section": "1.05",
   "Subsection": "a"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001437749-25-008832-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-25-008832-xbrl.zip
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M$U+Q]K0$XCH!10P@:1#XED-(&DM&YUI#%K4/TS_=%OUDZZ@M>8F!G?!6NI#
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M"W)B7VGA,GN5'K[_&9>>)R]=XFRK>8 I$(V2W\_"_Z[ =2>"I29;N'%7,\M
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M01"'R%FG:1.VWE\?_=OH+O]YQ7[]\@/NPXP2:KP-G,,H /<AMBT8A[H,%O4
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MM5"@_)]IG,C^:$I&_?;EZ^75E\\6RA;=!Q!<FIB6AEWV$\U3>W]<+A=P[V4
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MYB)C/C0"MG0.Y3X8UX *M(,]U)Y1*\%M"*A ]J$$ZM_*G3(JV\#P[W^$+Y+
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M,H!4O(JHF61)73J(?\=M("LXQOOSI-)HBSFC.L5]F#NN+QGG[><LE*%*^:(
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M2IU,?IQRQ![Y'YW<"IC972N?K<+ OO,.5!NG7BEO9FX=9:E2\8H^G';T/L*
MQOY)Y'HJ-><(T^-)-$=<G)3!L$"Y6=Y6=+%K/R5HB6Z>&E0U,!\2*OTTCP/:
M@-$^69)\"$Z\A<XJUXX.&;K!D*Y2Y=>8H%*@]PR/"2MM4/;)35+0)[-K(:$F
MI)729J47PC@H^N\[O2S"!F><)_!#J'>=9!8\<L<H,<"0-I\"-QB,"F*:IF9[
M/Z.HI:<J>Y[E2YWZ 24_.JQF_*3SPDX^1H?R]$.5EW#J.;JG?&>Z>*9%3/X
MDS+YR Y2UYDJA_MEDP]Q(4X^BX>S7B_EG<Q^PXLD2:NZ"5##)TS"LKL6HP)G
MHHU>K9H+Y02C"R@3&[UTI6F$NN*[N#8Y'F(Q">+ 5V8]J$@*J-J/2,Q2)X@G
M9JG^)O9IE7EGT5>K-=&B2@?K,!;9/:@"JT(F<PJ=8*UN?NOD!52,F@:^G>5?
M1XZ4HH83)^.<JBHR]@.R^5:S_KO^GJ>P+,@%2KF:R9(C9'4J9+=V>7*D' @J
M!X3.[$Y1P+A5@9^ZZ:R9?^:&D2(/_:A&'-)&;=EPHHZ<'*%3Y,[UA7'&7/H%
MGIAQPS@4_)N:',5;D!-C9^D24R(A78$.3#R ]K7XP_LM59X@_J,-4ZI38H0%
MP-DRLE-/.9+B8DY9E69?=XWN#1Z_3NE);>4)4IE)4W^\_AU=_7-JY!7562<5
MU,S5C8[T!%;(6])+>]'AFW]<';$K@2[#3Y^.EMF+?P@?_@L<!-Z.E]E0;:^Y
MN\YVVYOUYL[.UC);PCNP__O/!*"--I")/C/19\N*/GON]*EZ0* N7^&KLP'W
MPVQW,I*."(_9;'R"Z6TAU+S0D]_4M65Y7R9BKF%X21)X/]Z+R>&L309Y+ZKB
M#%8[2$0U*?4D".'7\);%@2L=%@UZM:;%\-]Z7D8-<&ZQ'PTX_VYWOQ]^3C+G
M>SN'DZ'STGFWUL!=K,;[]MK".[U(NLXXO$"=CT=>K_*=AYG)^H\3,3D&[B6K
M/H0DXM)=]4&HA="I]ACN7@@5[_Q]%L)J#T$OA"4,0NL*Q1[.ZXX^^O-BA?<*
M"..B[O>L*L%7'\.UT'('.]3!$&CZB^A%!OU[?0?)Y5"(PN;)LZ@*E54#*B[B
M*R^^JRZ:*RMV*RY2C;@TXG)!@JI&/NT@C;GOQ.OWD$/'U9)#=H#N&__=&G0K
M7WJ%/L[R[2VLW]..QTI.^BP:3 %AZHS,W5A0+*1B8"B@M%I":S9*.P:ECT5I
MYUXH?3)!5Y[ZHH1[(G$V8P, Y[3=Q",_G5WXOZVM]>4)O6>59D<JCAZ#8\"D
M>OOT]M33&TKS6UR2Z3._P:49,]_A]$O08I_>[OC./#YE@TNS#2K,';>VB#&^
M;.XX[XST=_CD>$%G6Z!_7]R$?&>E+;7M:;UH[?#GV0MPNA_MI7:DI M1$ /T
M;=-J[^S.6Z_00S^XB7@(NF243F];+YEN=W+HSC,B:*EM/P!!T_UX!@2U.];6
M5G,>A#I5@E"%A,-K4)W/(Q%RL/_R="V%<TPEK?K5"HO'>B6>18S<K],S><5>
M:[L*LF:6F6T$T$)1^>2BZ1&H;%L[Z/)Y?@'V8[BLD%1[\29/_K\]E0: \KH:
M8?9];T,EC)TMJ[6W604!9&3-O4!3#?MF&TSD2HB'59($K\&^^9!&OJ2#@6C8
MH/.+TBU8S!=3Z>:-%*B,%&AM[1D98&3 @V3 3ML( &,*3 J 4S_A_D"J] -&
M]Z\VUV]9K4VSTV$8_P)18WC_ZU7^OZCTVOZ J:P-A)AZT*^GL98&SRD,[A5)
M9K8Z'LX2[CV.S78U/4T/1,;R)="/0-7L?RP2JEOSH?JL$F[5PF%?O,DS<_?C
M=5L^W]^)[,"R<X(4C<2)=5>5N+![=GBV@KQM[;6WJB#I)IE%QVSJ+Q>GS[W%
M_R"<@C72;NU40<S]&$XK).:>S+J[.T+?G+18:(/FI,7RYM&<M#"*]Z+.H;E2
MY6*6PAQ&,RS2L$C#(JNEM#TCB^S:-HR;;JD;J9SP>(FL;8-&?^<AA )+-6Z,
M!Q_GKZ@7XR$!X%M6IQHQ0>9@PM."]+E=& \!Z;:UVYKK:#.G%(RY<,]3"D;:
M57^7N4(BR4B?U8E6JHR(6"5I\!HLH\E@I4P&C%B=N0'(<KQCBLXMX"4QF:3
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ML*!,PRY<$F7$?<")TE9F6!MDU83A\R=02P,$%     @ N3AX6H]EK?S7!
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M5HY0\(=(S?2K&*O_!U!+ 0(4 Q0    ( +DX>%KR$J1[:"8  .TG   '
M          "  0    !A,#$N:G!G4$L! A0#%     @ N3AX6KY-J$$J(@
MSH0!  T              ( !C28  &5X7S<Y,S$Q,BYH=&U02P$"% ,4
M" "Y.'A:ATG>6'T#   9#@  $0              @ 'B2   ;6)R>"TR,#(U
M,#,R-"YX<V102P$"% ,4    " "Y.'A:CV6M_-<$  #E+   %0
M    @ &.3   ;6)R>"TR,#(U,#,R-%]D968N>&UL4$L! A0#%     @ N3AX
M6G343Z?U!0  0SP  !4              ( !F%$  &UB<G@M,C R-3 S,C1?
M;&%B+GAM;%!+ 0(4 Q0    ( +DX>%H8 );F<P0  'TM   5
M  "  <!7  !M8G)X+3(P,C4P,S(T7W!R92YX;6Q02P$"% ,4    " "Y.'A:
M ';A6-T.  !O6   $P              @ %F7   ;6)R>#(P,C4P,S(Q7SAK
:+FAT;5!+!08     !P ' +D!  !T:P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>mbrx20250321_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mbrx-20250324.xsd" xlink:type="simple"/>
    <context id="d20258K">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001659617</identifier>
        </entity>
        <period>
            <startDate>2025-03-24</startDate>
            <endDate>2025-03-24</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="d20258K" id="ixv-212">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="d20258K" id="ixv-213">0001659617</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="d20258K" id="ixv-223">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="d20258K" id="ixv-224">2025-03-24</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="d20258K" id="ixv-225">MOLECULIN BIOTECH, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="d20258K" id="ixv-39">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="d20258K" id="ixv-226">001-37758</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="d20258K" id="ixv-227">47-4671997</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="d20258K" id="ixv-228">5300 Memorial Drive, Suite 950</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="d20258K" id="ixv-229">Houston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="d20258K" id="ixv-230">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="d20258K" id="ixv-231">77007</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="d20258K" id="ixv-232">713</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="d20258K" id="ixv-233">300-5160</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="d20258K" id="ixv-234">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="d20258K" id="ixv-235">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="d20258K" id="ixv-236">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="d20258K" id="ixv-237">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="d20258K" id="ixv-238">false</dei:EntityEmergingGrowthCompany>
    <dei:Security12bTitle contextRef="d20258K" id="ixv-239">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="d20258K" id="ixv-240">MBRX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="d20258K" id="ixv-241">NASDAQ</dei:SecurityExchangeName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
